Pfizer has received U.S. Food and Drug Administration approval for depo-subQ provera 104 for the management of pain associated with endometriosis, a gynecological condition that affects one in ten women of reproductive age.
WebProWorld
Pfizer has received U.S. Food and Drug Administration approval for depo-subQ provera 104 for the management of pain associated with endometriosis, a gynecological condition that affects one in ten women of reproductive age.